Market Intelligence Resource | May 12, 2021
Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged ≥65 Years — United States, January To March 2021
On May 5, 2021, the U.S. Centers for Disease Control and Prevention (CDC) released these study results on the effectiveness of the Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged ≥65 Years — United States, January To March 2021. The report finds that coronavirus disease 2019 (COVID-19) vaccines significantly reduce the risk for
COVID-19–associated hospitalization in older adults and, in turn, might lead to commensurate reductions in post-COVID conditions and deaths . . .
Want To Read More? Log In Or Become A Paid Member
